Takuya Harada

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Expert review of clinical immunology

American journal of hematology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Shinichiro Tsunoda, Takuya Harada, Yoshikane Kikushige, Tadamitsu Kishimoto, Kazuyuki Yoshizaki
Immunology and targeted therapy in Castleman disease. Expert review of clinical immunology 20 (9) (2024)
Shinichiro Tsunoda, Takuya Harada, Yoshikane Kikushige, Tadamitsu Kishimoto, Kazuyuki Yoshizaki
Immunology and targeted therapy in Castleman disease. Expert review of clinical immunology (2024)
Teppei Sakoda, Yoshikane Kikushige, Toshihiro Miyamoto, Hidetoshi Irifune, Takuya Harada, Kiwamu Hatakeyama, Yuya Kunisaki, Koji Kato, Koichi Akashi
TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia. Blood advances (2023)
Takuya Harada, Yoshikane Kikushige, Toshihiro Miyamoto, Kazuko Uno, Hiroaki Niiro, Atsushi Kawakami, Tomohiro Koga, Koichi Akashi, Kazuyuki Yoshizaki
Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease. Nature communications 14 (1) (2023)
Yasuo Mori, Naoyuki Uchida, Takuya Harada, Yuta Katayama, Atsushi Wake, Hiromi Iwasaki, Tetsuya Eto, Satoshi Morishige, Tomoaki Fujisaki, Yoshikiyo Ito, Tomohiko Kamimura, Tsutomu Takahashi, Yutaka Imamura, Kazushi Tanimoto, Kenji Ishitsuka, Junichi Sugita, Noriaki Kawano, Kazuki Tanimoto, Goichi Yoshimoto, Ilseung Choi, Tomonori Hidaka, Ryosuke Ogawa, Yasushi Takamatsu, Toshihiro Miyamoto, Koichi Akashi, Koji Nagafuji
Predictors of impaired antibody response after SARS-CoV-2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study. American journal of hematology (2022)